Tech Company Financing Transactions

Qwell Pharmaceuticals Funding Round

On 1/6/2009, Qwell Pharmaceuticals raised $7 million in Series A funding from Arch Venture Partners and private investors.

Transaction Overview

Announced On
1/6/2009
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors

Arch Venture Partners (Lead Investor) (Steven Gillis)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1000 Second Ave. 3700
Seattle, WA 98104
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
The company develops therapeutics for anti-cancer activity.
Profile
Qwell Pharmaceuticals LinkedIn Company Profile
Social Media
Qwell Pharmaceuticals Company Twitter Account
Company News
Qwell Pharmaceuticals News
Facebook
Qwell Pharmaceuticals on Facebook
YouTube
Qwell Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
   LinkedIn Profile   Twitter Account   News   on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/5/2009: Superfish venture capital transaction
Next: 1/6/2009: RipCode venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary